ThermoGenesis Holdings Inc

NASDAQ:THMO  
2.81
-0.05 (-1.75%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)32.54M
Current PEN/A
Forward PE N/A
2yr Forward PE 21.62
See more stats
Estimates Current Quarter
Revenue$1.99 Million
Adjusted EPS-$0.18
See more estimates
10-Day MA$2.83
50-Day MA$2.61
200-Day MA$2.71
See more pivots

ThermoGenesis Holdings Inc Stock, NASDAQ:THMO

2711 Citrus Road, Rancho Cordova, California 95742
United States of America
Phone: +1.916.858.5100
Number of Employees: 41

Description

ThermoGenesis Holdings, Inc. engages in the research, development, commercialization, and marketing of automated cell processing technologies for the cell and gene therapy field. It operates through the Device and Clinical Development segment. The Device segment includes the development and commercialization of automated technologies for cell-based therapeutics and bioprocessing. The Clinical Development segment utilizes autologous stem cell-based therpeutics. The company was founded by Philip H. Coelho in 1986 and is headquartered in Rancho Cordova, CA.